Dr. Leal aims to give strength to the voice of pharmacists
MOORESTOWN, N.J., March 19, 2021- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing safe use of medication, announced Sandra Leal, PharmD, TRHC executive vice president, has been elected President of the American Pharmacists Association. Dr. Leal assumed her position as president for the next three years at the 2021 APhA Annual Meeting and Exposition held virtually March 15, 2021.
In her acceptance speech entitled, “Be the Voice,” Dr. Leal emphasized the importance of being the voice of change and creating a dialogue for others who cannot speak for themselves. She is an advocate for creating an environment that values trusting relationships with patients and clients and believes that the key attribute of a leader is not being afraid to speak out.
“My role as APhA President aims to give strength to each of your voices,” said Leal. “I have always been an advocate for change, especially for people with the most challenge.”
At Tabula Rasa Healthcare, Dr. Leal leads SinfoniaRx, a TRHC solution. SinfoniaRx works with payers, health systems, and community pharmacists to improve medication management and safety through telehealth solutions.
“Tabula Rasa Healthcare is proud to have such a dedicated and patient-oriented team member as Dr. Leal,” said Chairman and CEO Calvin H. Knowlton, PhD. “We anticipate with confidence and excitement all Dr. Leal and her colleagues at APhA will accomplish under her leadership.”
Dr. Leal received her PharmD from the University of Colorado and her MPH in Public Health Practice from the University of Massachusetts. Dr. Leal joined SinfoniaRx in 2015 as vice president for innovations.
“Thank you to my colleagues at Tabula Rasa HealthCare who are finding innovative ways to address medication safety,” said Dr. Leal.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) provides medication safety solutions empowering pharmacists and prescribers to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise™, TRHC improves patient outcomes, reduces hospitalizations, and lowers healthcare costs. Additionally, TRHC provides an extensive clinical telepharmacy network across the U.S. Our solutions are trusted by health plans and pharmacies nationwide to help drive value-based payment results. For more information, visit TRHC.com.
TRHC Media Contact:
T: (215) 870-0829